Eli Lilly and Company’s investigational drug, retatrutide, a groundbreaking triple hormone receptor agonist, has delivered an average weight loss of…
Read More

Eli Lilly and Company’s investigational drug, retatrutide, a groundbreaking triple hormone receptor agonist, has delivered an average weight loss of…
Read More
A groundbreaking study involving over 23andMe customers has identified genetic variations in two key genes that significantly influence both the…
Read More
A large-scale study analyzing the genetic data of 23andMe customers has identified specific variants in two genes that significantly influence…
Read More